Professionals 221 Users Online

Cell Culture Media Market

High use of cell culture media for chemotherapeutic research is expected to boost the global market growth in future

Cell Culture Media Market Segmented By Serum-Containing Media, Serum-Free Media, Protein-Free Media, Chemically-Defined Media

Cell Culture Media Market Outlook (2023-2033)

Worldwide revenue from the cell culture media market stands at US$ 3.0 Bn in 2022, with the global market forecasted to surge ahead at a CAGR of 6.8% to reach a valuation of US$ 6.3 Bn by the end of 2033.

The global market for cell culture media recorded a historic CAGR of 6.1% in the last 7 years from 2014 to 2021. Overall, cell culture media sales accounted for 19% of the US$ 16.3 Bn global cell culture market in 2021.

Cell culture is a process for harvesting cells in an in-vitro setting. Typically, cells need nutrient-rich medium and a sterile environment to thrive properly. The media used in cell culture is often semi-solid, liquid, or gel-based and is created to facilitate cell growth. Amino acids, glucose, inorganic salts, and serum that promotes cell development often make up cell culture media.

The market will rise during the forecast period due to rising disease treatments utilising artificial organs and tissue grafts as well as funding for research. The market for cell culture media is also expanding due to the benefits of culture media in tissue or organ recovery.

Over the forecast period, a rise in the production of biopharmaceutical medicinal products is anticipated to boost demand for cell culture media. More than 1000 biopharmaceutical products are being developed for the market in the US and Europe, and over 80% of those products are made in mammalian cell culture systems. This demonstrates the substantial number of biopharmaceuticals under research.

One of the key factors propelling the growth of the cell culture media market is the rising incidence of cancer. Cancer is the second leading cause of mortality, according to the WHO. Globally, the burden of chronic diseases is rising quickly. Thus, it is projected that the market for cell culture media would grow as a result of rising demand for treating chronic diseases in a personalized manner, which has increased expenditure on cell culture development.

Furthermore, academics are favouring unconventional approaches to discover new ways to treat diseases, which is driving a rapid increase in the number of clinical trials in the biopharmaceutical industry and academic research using biopharmaceuticals. As a result, there will be an increase in the demand for cell culture media in the future.

Attributes Key Insights

Cell Culture Media Market Size (2022)

US$ 3.0 Bn

Projected Market Value (2033)

US$ 6.3 Bn

Global Market Growth Rate (2023-2033)

6.8% CAGR

Market Share of Top 4 Countries


Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Why is the Global Cell Culture Media Market Growing?

Introduction of Regenerative Medicine for Treatment of Diseases

The development of medicines that can lessen transplantation by grafting tissue using cell culture media as nutrient is being driven by the loss of organs and tissues as a result of disease and injury. In the recent years, tissue engineering has advanced. Cartilage, ligaments, bones, muscles, and blood vessels are among the tissues that can be produced in a laboratory setting. The market will rise during the forecast period due to rising disease treatments utilising artificial organs and tissue grafts as well as funding for research.

“Increasing Production of Antibodies for Treatment of Disease”

In the upcoming years, it is anticipated that the market will grow due to an increase in the development of monoclonal antibodies employing cell culture media. Culture media-based cell culture technology has been shown to be a dependable, effective, and relatively developed technique. In vitro research has produced numerous synthetic antibodies utilising a variety of cell lines. Numerous auto-immune illnesses have been treated with monoclonal antibodies. These monoclonal antibodies were created utilising a variety of cell culture medium, which fuelled market expansion for cell culture media.

“Introduction of New Cost-Effective Cell Culture Media”

A significant possibility for the expansion of the cell culture media industry is the introduction of affordable cell culture media. The development of cost-effective cell culture medium as a result of the use of novel methods for the manufacturing of serum-free media is expected to fuel market expansion during the following years. Because it is less expensive than media that contains serum, serum-free culture media is anticipated to see widespread adoption.

  • While there is large production of cell culture media in North America, Europe, and some regions of Asia Pacific, the biopharmaceutical market in Latin America, the Middle East, and Africa has little access to it. Consequently, it offers enormous opportunities for manufacturing products at a low cost and expanding availability.
Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

Can Demand for Cell Culture Media Be Affected in Any Way?

High R&D Cost Hampering Market Growth”

One of the major factors preventing the market's overall expansion is the high cost of research and development operations. Each ingredient in cell culture medium, such as amino acids, proteins, and sugars, must be added in a certain ratio, driving up the price of the media and impeding market expansion overall. Another significant factor that could reduce the manufacturing of cell culture media is a lack of skilled personnel, particularly in developing countries.

“Increasing Concerns Related to Sterility of Culture Media”

The preparation and maintenance of cell culture media raise a number of concerns that could hamper market expansion. The main priority is to prevent contamination of the cell culture media. There is a high probability that various cell types in medium may become contaminated. The likelihood of microbial and chemical contamination using in-vitro techniques is significant. Contamination can result from a variety of substances, although it typically results from the lab setting. Additionally, expertise is needed to prevent any cellular contamination in the culture media. All of these elements may slow the market's expansion for cell culture media.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Country-wise Insights

Why is the U.S. a Huge Market for Cell Culture Media Manufacturers?

“Rising Investments and Government Support”

The U.S. accounted for around the largest share of the North American market in 2022, contributing nearly US$ 903.8 Mn in terms of revenue, and a similar trend is expected over the forecast period.

The rise of the biotechnology and pharmaceutical industries, rising investments in cell-based research, rising regulatory approvals for cell culture-based vaccines, and strong government support are all contributing to the expansion of the U.S. market for cell culture media.

What is the Scenario for Cell Culture Media Market in Germany?

“Partnerships between Manufacturers and Government Associations”

Germany held 26.2% share of the European market in 2022.

The market in this region is being driven forward by factors like growth in the European biopharmaceutical industry, an increase in government initiatives to support research to find a cure for the rising number of chronic diseases, an increase in pharmaceutical manufacturers, improving economies, high disposable income per person, and increased healthcare spending.

How is China Emerging as a Prominent Market for Cell Culture Media?

“Rising Instances of Cancer”

China held the largest market share of 65.8% of the East Asia market in 2022.

  • According to the NCBI report, China will experience 3,210,000 cancer deaths and 4,820,000 new instances of cancer in 2022. Lung cancer is the most prevalent cancer in China and the main reason for cancer-related deaths in the country. With the number of cancer patients increasing, there will be significant research and development efforts to create tissues in vitro using cell culture.

Due to a large number of research organizations, low labour and manufacturing costs, expanding healthcare infrastructure, and rising investments by international market leaders in the country, Chinese market is booming.

Sales Team

Sales Team
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert
I'm Available

Category-wise Insights

Which Product is Largely the Focus in the Global Market?

“Efficiency and Effectiveness of Serum-Free Media”

The serum-free media segment dominated the market generating a revenue of US$ 1.5 Bn in 2022.

Rising R&D expenditure for cell-based diagnostics is one of the major factors impacting the dominance of serum-free media. Various medical organizations and biopharmaceutical companies are working together on molecular genetics, cell biology, cancer research, and plant research using serum-free media as a treatment option in order to facilitate efficient assessment and monitoring.

Which Application Segment Displays Greater Adoption of Cell Culture Media?

“High Use of Cell Culture Media for Chemotherapeutic Research”

Cancer research held the largest market share under the application segment globally in 2022. The segment contributed revenue of US$ 1.3 Bn in 2022.

The ongoing rise in cancer cases spurs researchers to continually create and look for novel treatments alongside the rapid advancement of cancer treatments and medications. Another highly noticeable tendency in the development of novel in vitro animal models for chemotherapeutic research is the idea of an inseparable element. Before using animals for testing, research models frequently use cell cultures. They serve as the foundation for the creation of novel cancer treatments and diagnostics.

Which End User Segment is Dominant in the Global Market?

The biopharmaceutical companies led the market under the end user segment generating a revenue of US$ 2.5 Bn in 2022.

The demand for cell cultures from biopharmaceutical companies is rising as a result of the expanding use of cell cultures in pharmaceutical research for drug test, ecotoxicology, biological products, gene therapy, and regenerative medicine.

Competitive Landscape

Leading manufacturers are incorporating effective and efficient media cultures to bolster their product ranges globally. Several significant competitors in the cell culture media sector have carried out similar consolidation actions such as mergers and acquisitions. The expansion of company partnerships to improve their cell culture media in chemotherapeutic research is another important strategy observed in the sector.

For instance:

  • In March 2020, the life sciences division of General Electric Company sold the biopharma business to Danaher Corporation (US). The life sciences division of Danaher now manages it as a separate business unit. After being acquired by Danaher, the company is currently known as Cytiva.
  • In July 2021, the cell culture authority Xell AG was purchased by Sartorius through its subsidiary Sartorius Stedim Biotech. The company develops, produces, and sells culture and feed additives for cell cultures, primarily for the production of viral vectors used in the production of vaccines and gene therapies.

Similarly, recent developments related to companies providing cell culture media have been tracked by the team at Persistence Market Research, which are available in the full report.

Cell Culture Media Industry Report Scope

Attribute Details

Forecast Period


Historical Data Available for


Market Analysis

USD Billion for Value

Key Countries Covered

  • U.S.
  • Canada
  • Brazil
  • Mexico
  • Argentina
  • U.K.
  • Germany
  • Italy
  • Russia
  • Spain
  • France
  • India
  • Thailand
  • Indonesia
  • Malaysia
  • Japan
  • China
  • South Korea
  • India
  • Indonesia
  • Malaysia
  • Thailand
  • Australia
  • New Zealand
  • Turkey
  • GCC Countries
  • Northern Africa
  • South Africa

Key Market Segments Covered

  • Product
  • application
  • end user
  • Region

Key Companies Profiled

  • Becton, Dickinson and Company
  • Hi-Media Laboratories
  • Merck, KGaA
  • STEMCELL Technologies Inc.
  • Cell Sciences, Inc.
  • GE Healthcare
  • PAN Biotech
  • MP Biomedicals, LLC.
  • PromCell GmbH
  • Irvine Scientific
  • Lonza
  • Corning Incorporated

Report Coverage

  • Market Forecast
  • Competition Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Segments of Cell Culture Media Industry Research

By Product:

  • Serum Containing Media
  • Serum Free Media
    • Protein Expression Media
    • Stem Cell Media
    • Hybridoma Media
    • Primary Cell Media
    • Insect Cell Media
    • Immunology Media
    • CHO Cell Culture Media
  • Protein Free Media
  • Chemically Defined Media

By Application:

  • Cancer Research
  • Biopharmaceuticals
  • Regenerative Medicine & Tissue Engineering
  • Stem Cell Technologies
  • Others

By End User:

  • Biopharmaceutical Companies
  • Clinical Research Organizations
  • Academic Research Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

- Companies Covered in This Report -

  • Becton, Dickinson and Company
  • Hi-Media Laboratories
  • Merck, KGaA
  • STEMCELL Technologies Inc.
  • Cell Sciences, Inc.
  • GE Healthcare
  • PAN Biotech
  • MP Biomedicals, LLC.
  • PromCell GmbH
  • Lonza
  • Corning Incorporated
  • Irvine Scientific

- Frequently Asked Questions -

The global cell culture media market stands at US$ 3.0 Bn in 2022.

Sales of cell culture media are set to witness high growth at a CAGR of 6.8% and reach US$ 6.3 Bn by 2033.

Demand for cell culture media increased at 6.1% CAGR from 2014 to 2021.

North America, Europe and East Asia account for the most demand for cell culture media, currently holding 80.3% market share.

The U.S. accounts for the largest share of the North American market, contributing revenue of around US$ 903.8 Mn.

Becton, Dickinson and Company, Merck KGaA and GE Healthcare are the top three manufacturers of cell culture media.

China held a share of 65.8% in the East Asia market in 2022, while Japan is estimated to grow at a CAGR of 7.7%.

Demand for cell culture media in Europe is estimated to grow at a CAGR of nearly 6.4% over the forecast period.

Rise in the production of biopharmaceutical medicinal products, rising incidence of cancer and increased demand of cell culture in academic and research institutions for research purposes are some of the key trends in this market.

UK market is set to expand at a CAGR of 7.0% through 2033.

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate